Delivery Order SPE2DB22D1106-SPE2DB24FDWX7
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, worth $1,050.64, is for the delivery of Prilosec DR 2.5 mg suspension medication. The contract is a Firm Fixed Price Delivery Order that will run through March 28, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract (SPE2DB22D1106|SPE2DB24FEHP3) worth $2,243.05 by the Defense Logistics Agency (DLA) Troop Support Medical to provide Prilosec DR 10 mg suspension medication. This delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to deliver pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,963.98 to AmerisourceBergen Drug Corp for the supply of Prilosec DR 10 mg suspension (30 count) on December 17, 2025, with an ultimate completion date of December 18, 2025. This is a firm fixed price delivery order with no set-aside designation, utilizing a competitive award process. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,198,487 units of omeprazole delayed-release 40 mg capsules. The contract has a total ceiling value of $2,256.48 and a completion date of February 7, 2025. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,803 units of the prescription drug Omeprazole DR 20 mg Capsule, with a ceiling value of $1,095.82 and a completion date of December 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- The Defense Logistics Agency awarded a delivery order valued at $11,163.12 to AmerisourceBergen Drug Corp for the supply of Prilosec DR 10 mg Suspension in 30-count packaging. This firm fixed-price contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $10,156.92 to AmerisourceBergen Drug Corp for the supply of Prilosec DR 10 mg suspension (30-count). This firm fixed-price delivery order, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a non-set-aside award executed through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued as a child...
- This federal contract award, with ID SPE2DB20D3101|SPE2DB23FRYE3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $25,395.84 firm-fixed-price delivery order is for the supply of Prilosec DR 10 mg suspension in 30-count packages. The contract has an ultimate completion date of September 20, 2023. The award was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,262.62 firm fixed-price delivery order is for the supply of 1,000 units of 40 mg Omeprazole delayed-release capsules. The contract has a period of performance through May 6, 2024 and was awarded on May 3, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite...
- The Defense Logistics Agency (DLA) awarded a $2,707.56 delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of First-Omeprazole 2 mg/ml suspension medication. This delivery order was placed under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally....
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FDWX7Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Prilosec DR 2.5 mg suspension medication. The contract has a total ceiling value of $3,271.65 and an ultimate completion date of January 25, 2024. It is a firm-fixed-price contract, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 1/24/24 |